Holders — by stockHoldings — by fund
Eagle Health Investments LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001842545
$603.3M
disclosed book value
27
positions
11.8%
largest position share
Positions, as of 2026-06-30
top 27 of 27 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ARGXARGENX SE | 76,417 | $70.9M | 11.8% |
| 2 | ICLRICON PUB LTD CO | 308,143 | $53.5M | 8.9% |
| 3 | GHGUARDANT HEALTH INC | 300,685 | $45.1M | 7.5% |
| 4 | INSMINSMED INC | 384,130 | $41.0M | 6.8% |
| 5 | BMRNBIOMARIN PHARMACEUTICAL INC | 624,676 | $35.7M | 5.9% |
| 6 | ILMNILLUMINA INC | 187,413 | $33.0M | 5.5% |
| 7 | SRRKSCHOLAR ROCK HLDG CORP | 555,272 | $30.5M | 5.1% |
| 8 | PTGXPROTAGONIST THERAPEUTICS INC | 248,322 | $30.4M | 5% |
| 9 | RAREULTRAGENYX PHARMACEUTICAL IN | 884,121 | $29.5M | 4.9% |
| 10 | CMPSCOMPASS PATHWAYS PLC | 2.1M | $29.2M | 4.8% |
| 11 | ASNDASCENDIS PHARMA A/S | 106,158 | $28.3M | 4.7% |
| 12 | RVMDREVOLUTION MEDICINES INC | 120,346 | $22.5M | 3.7% |
| 13 | FTREFORTREA HLDGS INC | 1.2M | $20.6M | 3.4% |
| 14 | KYMRKYMERA THERAPEUTICS INC | 166,148 | $19.1M | 3.2% |
| 15 | AXSMAXSOME THERAPEUTICS INC. | 65,051 | $15.9M | 2.6% |
| 16 | BSXBOSTON SCIENTIFIC CORP | 369,164 | $15.8M | 2.6% |
| 17 | ALKSALKERMES PLC | 297,302 | $15.6M | 2.6% |
| 18 | IONSIONIS PHARMACEUTICALS INC | 194,577 | $15.4M | 2.6% |
| 19 | TEMTEMPUS AI INC | 256,269 | $14.8M | 2.5% |
| 20 | DNTHDIANTHUS THERAPEUTICS INC | 131,344 | $12.8M | 2.1% |
| 21 | ATAIATAIBECKLEY INC | 1.7M | $9.0M | 1.5% |
| 22 | AVTXAVALO THERAPEUTICS INC | 235,093 | $4.3M | 0.7% |
| 23 | NTRANATERA INC | 15,847 | $4.3M | 0.7% |
| 24 | LLYELI LILLY & CO | 1,994 | $2.4M | 0.4% |
| 25 | ISRGINTUITIVE SURGICAL INC | 4,390 | $1.7M | 0.3% |
| 26 | IMCRIMMUNOCORE HLDGS PLC | 46,300 | $1.5M | 0.2% |
| 27 | FRNMPERCEPTIVE CAP SOLUTIONS COR | 37,686 | $410,024 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.